Chronic suppurative otitis media (CSOM) is one of the most common chronic infectious diseases worldwide, especially affecting children. The patients or the parents of the affected children are often worried about the cost of medical visits, prescription medicines, or inconsistently effective medication. The complications of CSOM have been greatly reduced because of the development of antibiotics; however, the irrational use of antibiotics has led to the emergence of organisms resistant to the commonly used drugs. Owing to the increase in antibiotic resistance, the development of new treatments that will efficiently eradicate infectious microorganisms has become imperative. Boric acid solutions are effective in the treatment of CSOM because of their acidic effect. Various databases, such as the PubMed, The Cochrane Library, and SciELO, were searched for references related to the efficacy of boric acid in the treatment of mucosal CSOM, as well as its ototoxicity. The search revealed that boric acid is relatively effective in treating CSOM, especially at a high concentration. Boric acid in distilled water was found safe in animal studies. However, the ototoxicity of boric acid concentrations higher than 4% needs further evaluation, considering the effectivity of boric acid at high concentrations.
INTROduCTION
Chronic suppurative otitis media (CSOM) is characterized by persistent drainage from the middle ear associated with a perforated ear drum. Otoscopic examination of patients with CSOM reveals a red and inflamed middle ear with purulent discharge. CSOM is one of the most common chronic infectious diseases worldwide, affecting 65-330 million people especially in the developing countries. It usually develops in the early years of life but can persist during adulthood. A study in Indonesia found that 116 of the 7,005 children examined had CSOM. 1, 2) CSOM is considered a multifactorial disease caused by a complex series of interactions between environmental, bacterial, host, and genetic risk factors. Although several factors play a role in the etiology of this disease, it is most commonly associated with the recurrent attack of otitis media during childhood. 1, 3) If CSOM is not treated properly, it can result in many complications. The complications of CSOM can be classified as extracranial or intracranial, and occur more often in atticoantral-type CSOM than in tubotympanic CSOM. [4] [5] [6] The complications of CSOM have been greatly reduced because of the development of antibiotics. However, the irrational use of antibiotics has led to resistance in the organisms to the commonly used drugs. another antiseptic agent, is also effective because of its acidic characteristics. Moreover, its ototoxic effect has been assessed in many animal studies, albeit with inconsistent results. 8, 9) Difficulties in treating the chronic infection can also be related to biofilm formation. Biofilms are involved in many chronic infections including multiple otorhinolaryngological diseases, such as chronic rhinosinusitis, cholesteatoma, adenotonsillitis, and chronic otitis media. Biofilms are formed by many bacteria, including the most common causative organism of CSOM. These biofilms periodically release planktonic bacteria into the host, resulting in disease recurrence. Owing to a strong relationship between biofilms and infection chronicity, experts have been actively seeking antibiofilm agents to treat chronic infection, and one such agent is boric acid. Boric acid was found to have an antibiofilm effect against some bacterial strain cultures. [10] [11] [12] [13] In this review, we investigated the efficacy of boric acid in treating CSOM, as well as its ototoxicity.
METhOdOLOgy
Various databases, such as the PubMed, The Cochrane Library, and SciELO, were searched to identify relevant articles. We focused our review on studies using boric acid for the treatment of mucosal CSOM and investigating its ototoxicity, with no publication date limitation.
We searched using the term "BORIC ACID" AND OTITIS MEDIA OR CSOM OR OTITIS MEDIA SUPPURATIVE, and selected only articles on humans with mucosal CSOM without complication and surgical intervention, or in vitro analysis of bacteria causing CSOM. The search for articles on ototoxicity was performed using the terms BORIC ACID and OTOTOXIC. Publications in languages other than English and review articles were not included in this review.
STudy SELECTION
A total of 24 articles were identified, from which 8 were removed as these were duplicates ( Figure 1 ). The titles and abstracts of the remaining articles were reviewed, and 9 that were judged to not have met the inclusion criteria were excluded. Finally, 7 articles were included in this review of the efficacy of boric acid in treating CSOM or CSOM bacteria in vitro. For reviewing the ototoxicity of boric acid, we found 4 articles that all met the inclusion criteria. Therefore, we included all 4 articles reporting on the ototoxicity of boric acid in this review. can be reduced, one of which is the activity of the protease enzyme produced by the bacteria, which reduces the formation and toxicity of their end products. 14) An acidic environment also influences the release of oxygen, which is the basic requirement for cell survival. The majority of the oxygen is required to produce oxygen radicals, which are the mainstay of immunity against bacterial infections. A low pH leads to the Bohr effect.
Lowering the pH by 0.9 units produces a 5-fold increase in the release of oxygen. The delivery of oxygen to damaged tissue depends on perfusion as well as diffusion. Good tissue oxygenation increases resistance to infection and promotes healing. Oxygen is also required for the synthesis of collagen and epithelialization. 14) Various acids have been proven to increase the effectiveness of topical antimicrobials. For example, the use of boric acid with vancomycin has been shown to be more effective than the use of boric acid or vancomycin alone in reducing the number of methicillin-resistant Staphylococcus aureus bacteria in a rat model of tibial osteomyelitis.
15)

BORIC aCId FOR ChRONIC SuppuRaTIvE OTITIS MEdIa TREaTMENT
The first step in treating active tubotympanic CSOM is to render it inactive. Various studies have examined treatment options. An aural toilet with dry mopping alone or dry mopping with saline has been shown to be less effective than is a combination of antibiotics, antiseptics, or steroids. Further, topical agents are better than systemic agents. 16, 17) However, there is no consensus among general physicians and otolaryngologists regarding the optimal management therapy for Boric acid is derived from boron, which has a high affinity for ribose, a constituent of several essential biological molecules, including ATP (adenosine triphosphate), NADH (nicotinamide adenine dinucleotide), NADPH (nicotinamide adenine dinucleotide phosphate), and RNA. Excessive amounts of boron can impair protein synthesis and the activities of serine-protease, b-lactamase, and amino-acyl tRNA synthetase, which are enzymes in the microorganism that cause mitochondrial dysfunction and disrupt cell division and development. Increased boron concentration may also affect quorum sensing, which is a vital mechanism in microorganisms. Boron is required for the maintenance of the structure and function of cell membranes, and excess boron impairs membrane function, integrity, conformation, and transport capacity. 12, 27) The effect of boric acid on biofilms has gained attention in recent years, as it has been found to inhibit biofilm formation in some bacte- Zan et al. 13) conducted a study evaluating the antibacterial effect of different concentrations of boric acid on Enterococcus faecalis biofilms in human root canals. He found that increased concentrations of boric acid showed a strong relation to its antibacterial effect. In a comparison among 2%, 4%, and 6% concentrations of boric acid, the 6% concentration had the highest antibacterial effect, reducing 69% of biofilms in cultures.
Although the exact mechanism underlying the antimicrobial effects of boric acid remains unclear, boric acid has been found to have bacteriostatic, bactericidal, and antibiofilm effects. Therefore, boric acid alone or in combination with another antibiotic can be the treatment of choice for recurrent or chronic infection. 13, 15, 26) 
EFFICaCy OF BORIC aCId IN paTIENTS wITh ChRONIC SuppuRaTIvE OTITIS MEdIa
Studies on the efficacy of boric acid in CSOM have yielded varying re-
sults. An in vitro study showed that 4% boric acid was not as effective as 100% and 50% Burow's solution, 2% acetic acid, or vinegar in water
(1:1) in inactivating several strains of bacteria. The tested bacteria were isolated during antibiotic susceptibility testing of patients with CSOM.
Although boric acid still has an antibacterial effect, the time required to inactivate 90% of the microorganism population was the highest for boric acid. 31) Macfadyen et al. 32) also found that boric acid was less effective than ciprofloxacin drops in treating ear discharge in patients with CSOM. This research showed similar result to the previous one.
Eason et al., 33) in 1986, reported that boric acid produced no additional benefit over aural toilet alone. In these studies, boric acid was used at relatively low concentrations (2%). Therefore, we assumed that the concentration of boric acid is related to its antimicrobial effect (Table   1) . A study evaluating the bactericidal effect of boric acid also found that at 0.5%, 0.75%, and 1% concentrations, boric acid does not have any bactericidal effect. 34) Several studies have found that boric acid was effective in treating CSOM. Minja et al. 17) reported that boric acid had a more significant effect than did dry mopping alone in patients with CSOM, without any hearing impairment. They also found that adding oral amoxicillin had no significant effect on the treatment outcome. A study by Moshi et al. 35) evaluated pus swab specimen cultures from 150 patients with chronic otitis media, and found that 3% boric acid in a spirit ear drop was effective in inhibiting P. aeruginosa growth. This research also determined the shelf life of 3% boric acid in the spirit ear drop and showed that this solution was effective even after it had been stored at room temperature for 6 weeks. Loock 16) applied boric acid powder directly to the external ear canal (EAC) after the EAC was flushed with saline to treat CSOM, and had very satisfying results. Boric acid powder was superior to 1% acetic acid and ciprofloxacin drops. We assumed that the boric acid powder applied directly to the EAC had a higher concentration than did 2% or 4% boric acid with distilled water or alcohol. A high concentration of boric acid can be the key to successful treatment (Table 1) .
We also found one case report describing the use of boric acid for treating nontuberculous mycobacterial infection. The patient had a poor response after being administered antibiotics for 7 months. He continued to show signs of right-sided CSOM. His middle ear cultures remained positive. 36) The patient received boric acid in powder form instilled into both ears weekly for 1 month, and monthly thereafter for a total of 3 months. After 1 month of topical treatment, the patient showed almost complete resolution of otorrhea without any side ef-
fects. This case report shows the potency of boric acid powder (Table   1 ).
36)
OTOTOxIC EFFECT OF BORIC aCId
Ototoxicity refers to the injury to inner ear structures caused by the administration of medications or chemicals. This toxicity to the inner ear structures could be related to the cochlea, vestibule, or both. 37) Some animal studies have investigated the ototoxic potential of boric acid. 38) In a study by Minja et al., 17) a boric acid solution prepared with 70% alcohol was used in children diagnosed with suppurative otitis media.
They reported that the boric acid solution prepared with 70% alcohol was effective in treating these patients. 
Case report A 2-year-old boy Canada CSOM Topical boric acid powder was successfully used for treating these patients with CSOM due to a nontuberculous mycobacterial infection, for which systemic antibiotic therapy was unsuccessful.
CSOM, chronic suppurative otitis media; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; QRPA, quinolone-resistant Pseudomonas aeruginosa; QSPA, quinolone-susceptible Pseudomonas aeruginosa.
some patients before and after treatment, and the thresholds improved after treatment in other patients.
We found some studies that evaluated the ototoxic effect of topical boric acid in normal animal cochlea. All of the studies involved perforation of the tympanic membrane under the microscope by using a pick. A gelfoam was inserted through the perforation in alignment with the round window, where boric acid was applied twice a day. 9, 37, 38) In the first research, Ozturkcan et al. 37) reported their results of the comparison of a 4% boric acid solution prepared with 70% alcohol group, a saline group, and a 4% boric acid solution prepared with distilled water group. The solutions were administered to the ear at a dose of 0.1 mL (two drops) for 10 days. On the 15th day, the auditory brain- was conducted 5 days after the 10-day administration period ( Table 2 ).
The latest research by Salihoglu et al. 39) showed an interesting method of boric acid application. They divided the animals into two groups and applied boric acid powder directly to the middle ear cavity through a tympanic perforation made using a surgical microscope. Inner ear function was detected using distortion product otoacoustic emission (DPOAE) at 2,000, 3,000, 4,000, 6,000, and 8,000 Hz, measured before and after perforation. After boric acid application, DPOAE and histological changes were evaluated on the 3rd day in group A and the 40th day in group B. Boric acid powder was applied 
Comparison of ototoxicity by measuring DPOAE results between 2 groups of animals.
Wistar albino rats
Turkey No significant differences were found at any of the DPOAE frequencies. Mild inflammation of the middle ear mucosa was found in groups A and B, which resolved over time.
Group A: DPOAE was measured before and after the perforation was made. DPOAE and histological changes were evaluated 3 days after the application of 35 mg boric acid. Group B: DPOAE was measured before and after the perforation was made. DPOAE and histological changes were evaluated 40 days after the application of 35 mg boric acid.
ABR, auditory brainstem response; DPOAE, distortion product otoacoustic emission.
https://doi.org/10.4082/kjfm.2018.39.1.2 directly into the middle ear, considering the powder would have the highest concentration. They found no significant changes in DPOAE and only mild inflammation of the middle ear mucosa, which resolved over time.
The other study by Ozdemir et al. 38) yielded the opposite result. They found no significant difference between the 4% boric acid in alcohol group and saline groups, as well as between the 4% boric acid in alcohol group and no treatment group. The effects of solutions on the animals were measured by using DPOAE amplitudes at 2,000, 2,800, 4,000, 6,000, and 8,000 Hz. Pretreatment and posttreatment measurements were performed at an interval of 15 days. They detected a minimal decrease in DPOAE amplitudes in the posttreatment frequencies, but this decrease was not statistically significant ( Table 2 ).
Alcohol has been found ototoxic in animal studies. Therefore, it would be a lot safer, especially in patients with a perforated tympanic membrane or an open mastoid cavity, to use boric acid in distilled water solution instead of boric acid in alcohol.
38,40)
CONCLuSION
Several studies have evaluated the efficacy of boric acid as a treatment for CSOM, but these have yielded mixed results. In our opinion, boric acid is relatively effective in treating CSOM, especially when used at high concentrations. It can be applied alone or in combination with antibiotics, but no study has investigated its specific application as an ototopical agent. The use of boric acid is expected to prevent the extensive use of antibiotics that can lead to microbial resistance; however, the use of boric acid as a first-line therapy needs further research.
Animal studies have shown that the application of 4% boric acid in distilled water for 10 days was safer than the application of boric acid in an alcohol preparation for the same duration. The direct application of boric acid powder was found relatively safe, suggesting that boric acid at a high concentration was safe and did not affect inner ear function. Nevertheless, the ototoxicity of boric acid solutions at concentrations higher than 4% needs further evaluation, considering this is the more applicable regimen as an ototopical agent.
